ImmunityBio, Inc. (IBRX)
ImmunityBio Market Cap : 7.978B for Aug. 24, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.205B |
| August 20, 2026 | 8.257B |
| August 19, 2026 | 8.563B |
| August 18, 2026 | 8.131B |
| August 17, 2026 | 8.342B |
| August 14, 2026 | 7.973B |
| August 13, 2026 | 8.057B |
| August 12, 2026 | 8.152B |
| August 11, 2026 | 8.004B |
| August 10, 2026 | 7.889B |
| August 07, 2026 | 8.047B |
| August 06, 2026 | 7.710B |
| August 05, 2026 | 7.593B |
| August 04, 2026 | 7.279B |
| August 03, 2026 | 7.488B |
| July 31, 2026 | 7.509B |
| July 30, 2026 | 7.803B |
| July 29, 2026 | 7.153B |
| July 28, 2026 | 7.300B |
| July 27, 2026 | 7.321B |
| July 24, 2026 | 7.436B |
| July 23, 2026 | 7.750B |
| July 22, 2026 | 7.866B |
| July 21, 2026 | 8.452B |
| July 20, 2026 | 7.850B |
| Date | Value |
|---|---|
| July 17, 2026 | 8.044B |
| July 16, 2026 | 7.803B |
| July 15, 2026 | 8.096B |
| July 14, 2026 | 8.253B |
| July 13, 2026 | 8.159B |
| July 10, 2026 | 8.609B |
| July 09, 2026 | 9.290B |
| July 08, 2026 | 9.217B |
| July 07, 2026 | 9.175B |
| July 06, 2026 | 9.332B |
| July 02, 2026 | 9.887B |
| July 01, 2026 | 9.636B |
| June 30, 2026 | 9.169B |
| June 29, 2026 | 9.185B |
| June 26, 2026 | 9.122B |
| June 25, 2026 | 8.159B |
| June 24, 2026 | 8.169B |
| June 23, 2026 | 7.667B |
| June 22, 2026 | 7.562B |
| June 18, 2026 | 7.708B |
| June 17, 2026 | 7.321B |
| June 16, 2026 | 7.038B |
| June 15, 2026 | 7.468B |
| June 12, 2026 | 7.436B |
| June 11, 2026 | 7.541B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.915B |
| Cogent Biosciences, Inc. | 6.219B |
| Moderna, Inc. | 55.39B |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
Market Cap Related Metrics
| PS Ratio | 45.84 |
| PEG Ratio | -0.0809 |
| Price | 7.575 |
| Earnings Yield | -12.79% |
| PEGY Ratio | -0.0809 |